Paracetamol/Propifenazona/Cafeina Laropharm (Paracetamol, Propyphenazone, Caffeine)

Paracetamol, the active ingredient in Paracetamol/Propifenazona/Cafeina Laropharm, is an analgesic and antipyretic presented as a combination tablet for oral use. It is used to relieve mild to moderate pain and reduce fever in adults and children.

GNH USA supplies Paracetamol/Propifenazona/Cafeina Laropharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paracetamol/Propyphenazone/Caffeine is an analgesic combination that acts on several pain‑related pathways. - Headache: Provides relief from tension‑type and migraine‑associated pain. - Dental pain: Reduces discomfort following dental procedures. - Musculoskeletal pain: Alleviates aches of back, muscle and joint inflammation. - Fever: Lowers elevated body temperature in febrile states. - Post‑operative surgical pain: Helps manage mild to moderate pain after minor surgery.

Paracetamol/Propyphenazone/Caffeine may cause a range of adverse reactions.

Common Side Effects: - Nausea or upset stomach - Headache - Dizziness - Insomnia - Mild skin rash

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Blood dyscrasias such as agranulocytosis - Hepatotoxicity, especially with high‑dose or chronic use - Gastrointestinal bleeding or ulceration - Stevens‑Johnson syndrome or toxic epidermal necrolysis

When using this analgesic combination, consider the following safety measures: - Assess the risk of liver injury: monitor liver function tests in patients with pre‑existing hepatic disease. - Evaluate the risk of bleeding or ulcer risk :   - Use the by  y   \

This ​   t  \\